Talya Miron-Shatz, PhD

CoFounder & CEO, CureMyWay

Ms. Miron-Shatz is a decision scientist specializing in medical decision making. Her research examines people’s understanding of health information, and ways of improving it. An important focus of her work is on adherence to medication, and developing scientifically valid interventions for improving adherence through behavioral means. Her work is published in peer-reviewed journals and in books (MIT, Oxford University Press).  She has a PhD from the Hebrew University in social and experimental psychology, and spent five years at Princeton University, as post-doctoral fellowship at Princeton University with Nobel Laureate Daniel Kahneman, and as a visiting research scholar. During this time she began teaching consumer behavior at Wharton, University of Pennsylvania, which she continues to do, with an emphasis on health consumerism. In addition to being a senior fellow at CMPI, Talya is a professor at the Ono Academic College, where she is founding director of the Center for Medical Decision Making. Dr. Miron-Shatz is CEO of CureMyWay, a start-up company developing personalized adherence solutions.